SWK Holdings Corporation is a specialty finance company in the healthcare sector with two main segments: Finance Receivables and Pharmaceutical Development. As a provider of customized financing solutions, it specifically caters to life science companies specializing in biotechnology, medical devices, diagnostics, animal health, and pharma. On top of this, it also offers non-discretionary investment advisory services to institutional clients and has a product pipeline that includes Ovarest, an oral leuprolide tablet to treat endocrine disease.